Log in to search using one of your social media accounts:

 

Overweight women may need more frequent mammograms
New research suggests heavier women are at greater risk of having breast cancer ​ detected after the tumor has grown large (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - November 20, 2017 Category: Consumer Health News Source Type: news

Samsung debuts new RS85 ultrasound scanner
Samsung Medison, an affiliate of Samsung Electronics, has introduced RS85,...Read more on AuntMinnie.comRelated Reading: Samsung debuts new mobile DR unit in U.S. Samsung launches new mobile DR unit Samsung taps executive to lead Medison division Samsung contributes to breast cancer patients Samsung showcases new CT system at RSNA 2015 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 20, 2017 Category: Radiology Source Type: news

NAFLD Linked to Increased Cancer Incidence Rate
NAFLD strongly tied to development of hepatocellular carcinoma, CRC in males, breast cancer in females (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 20, 2017 Category: Cancer & Oncology Tags: Family Medicine, Gastroenterology, Gynecology, Internal Medicine, Nursing, Oncology, Pathology, Radiology, Journal, Source Type: news

Overweight women need more frequent mammograms
Women who are overweight may need to be screened for breast cancer more often,...Read more on AuntMinnie.comRelated Reading: Major breast tomo trial opens for enrollment Tailored education gets Muslim women to mammography Women still value mammography's benefits over 'harms' How effective are mobile mammography programs? Annual breast screening reduces deaths by almost 40% (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 20, 2017 Category: Radiology Source Type: news

Heavier Women May Need Mammograms More Often
Overweight or obese women are at greater risk of having breast cancer detected after the tumor has grown large -- over 2 centimeters -- than their slimmer counterparts, the study found. (Source: WebMD Health)
Source: WebMD Health - November 20, 2017 Category: Consumer Health News Source Type: news

Breast cancer tumours 'larger' in overweight women
Women with a higher body mass index might need more frequent mammograms, researchers suggest. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - November 20, 2017 Category: Consumer Health News Source Type: news

Heavier Women May Need Mammograms More Often
MONDAY, Nov. 20, 2017 -- Women who are overweight or obese may need to be screened for breast cancer more frequently, new Swedish research suggests. The reason? Overweight or obese women are at greater risk of having breast cancer detected after the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 20, 2017 Category: General Medicine Source Type: news

Intermittent Letrozole Similar to Continuous Administration for Extended Breast Cancer Therapy
Taking temporary treatment breaks from letrozole following endocrine therapy for breast cancer is associated with similar disease-free survival as taking letrozole continuously, according to... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - November 20, 2017 Category: Primary Care Source Type: news

Can CEUS differentiate between IBD and colon cancer?
Is contrast-enhanced ultrasound (CEUS) effective for differentiating between...Read more on AuntMinnie.comRelated Reading: Artificial intelligence may help bridge experience gap for liver CEUS Contrast ultrasound clears up picture for renal lesions Contrast US helps assess breast cancer treatment response Contrast image processing boosts ultrasound performance What role should contrast US have for kidney lesions? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 20, 2017 Category: Radiology Source Type: news

Assessment of Major Depression After Breast Cancer Assessment of Major Depression After Breast Cancer
The ability to distinguish depressive symptoms from similar cancer-related somatic symptoms in women with breast cancer remains a challenge. How best should these patients be screened and treated?Southern Medical Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 20, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

UVA researchers discover a new target for 'triple-negative' breast cancer
(University of Virginia) One of the most difficult to treat cancers - triple-negative breast cancer - may be vulnerable to a new approach, an early study indicates. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 20, 2017 Category: Cancer & Oncology Source Type: news

Heavier Women May Need Mammograms More Often
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - November 20, 2017 Category: Cancer & Oncology Source Type: news

Breast cancer patients to have routine access to two life extending drugs after new deal say NICE
NICE has recommended palbociclib and ribociclib for routine funding after the companies lowered the prices and gave more evidence for their effectiveness. (Source: NHS Networks)
Source: NHS Networks - November 20, 2017 Category: UK Health Source Type: news

Only one in five Indonesian women are aware of cervical cancer screening
(European Society for Medical Oncology) Just one in five Indonesian women are aware of cervical cancer screening, according to a study presented at the ESMO Asia 2017 Congress. The research in nearly 5,400 women also found that only 5% knew about mammography for early detection of breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 18, 2017 Category: Cancer & Oncology Source Type: news

Risk of breast cancer recurrence lasts for decades
(Reuters Health) - Many women who follow initial breast cancer treatment with five years of hormone therapy to keep tumors at bay may still experience new malignancies up to two decades after their diagnosis, a study suggests. (Source: Reuters: Health)
Source: Reuters: Health - November 17, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Pfizer, Novartis Agree UK Price Cuts for New Breast Cancer Drugs Pfizer, Novartis Agree UK Price Cuts for New Breast Cancer Drugs
Pfizer and Novartis have agreed price cuts for their rival breast cancer drugs Ibrance (palbociclib) and Kisqali (ribociclib) to ensure they can be used routinely within Britain's state-funded health service.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 17, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Negligible Benefit Of Nerlynx, A New Breast Cancer Drug, Calls For Caution
The question for patients with early-stage HER2+ breast cancer is if it ’s worth taking a treatment (Nerlynx) that lowers the risk of distant recurrence by less than 2% at 5 years, and which has not yet been studied over the long term. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 17, 2017 Category: Pharmaceuticals Authors: Elaine Schattner, Contributor Tags: NASDAQ:PBYI VTX:ROG Source Type: news

The breast cancer symptoms that weren't lumps
EXCLUSIVE: Mothers Emily Nunn, 40, from Rotherham, South Yorkshire, and Katherine Vesey, 42, from the Wirral, Merseyside, first experienced (Source: the Mail online | Health)
Source: the Mail online | Health - November 17, 2017 Category: Consumer Health News Source Type: news

Novel therapeutic target discovered for estrogen receptor positive (ER+) breast cancer
(The Mount Sinai Hospital / Mount Sinai School of Medicine) Mount Sinai researchers identify new protein in a common subtype of breast cancer which can potentially offer more effective therapies for the future. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 17, 2017 Category: Cancer & Oncology Source Type: news

NICE gives green light to new 'breakthrough' breast cancer drugs
Discount price deals for two similar new breast cancer drugs have seen them approved for routine NHS use, under draft guidance from the National Institute for Health and Care Excellence. (Source: Nursing Times)
Source: Nursing Times - November 16, 2017 Category: Nursing Source Type: news

How a Tiny Breast Cancer Device Carries Big Value
With all the uncertainty in today's healthcare system, the one thing everyone seems to agree on is that value-based care is here to stay. Cianna Medical understands that particularly well, and the company's latest FDA clearance is expected to add even more value to the continuum of care for breast cancer patients and their providers. Cianna's Savi Scout reflector can now be implanted in breast cancer patients without restrictions on the length of time that it can remain in the breast. The device is a non-radioactive implant used in wire-free localization. It is only activated when a special handpiece, which acts as the rad...
Source: MDDI - November 16, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: Implants Source Type: news

Thousands to benefit as 'breakthrough' breast cancer drugs approved for NHS use
Annually, 8,000 women in England with previously untreatable advanced breast cancer will have access to drugs shown to slow disease ’s progressionThousands of women with previously untreatable breast cancer will have access to two “breakthrough” drugs that have been approved for NHS use.The drugs, called palbociclib and ribociclib, have been shown to slow the progression of advanced cancer by at least 10 months and can delay the need for chemotherapy, giving women the chance to live a normal life for longer. In new draft guidance, the National Institute for Health and Care Excellence (Nice) has approved t...
Source: Guardian Unlimited Science - November 16, 2017 Category: Science Authors: Hannah Devlin Tags: Breast cancer Health Society Science The National Institute for Health and Care Excellence (Nice) NHS Drugs Source Type: news

'Breakthrough' breast cancer drugs get NHS approval
Research shows the two new treatments can slow the cancer down and delay the need for chemotherapy. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - November 16, 2017 Category: Consumer Health News Source Type: news

Up to 8,000 women to benefit from new cancer drug
The drugs are hailed as the ‘closest thing to a cure’ for women with incurable breast cancer. Vikki Orvice (pictured), from St Albans, has been able to work full-time thanks to the wonder drugs. (Source: the Mail online | Health)
Source: the Mail online | Health - November 16, 2017 Category: Consumer Health News Source Type: news

Pfizer, Novartis agree UK price cuts for new breast cancer drugs
LONDON (Reuters) - Pfizer and Novartis have agreed price cuts for their rival breast cancer drugs Ibrance and Kisqali to ensure they can be used routinely within Britain's state-funded health service. (Source: Reuters: Health)
Source: Reuters: Health - November 16, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Metabolic recycling of ammonia via glutamate dehydrogenase supports breast cancer biomass
Ammonia is a ubiquitous by-product of cellular metabolism; however, the biological consequences of ammonia production are not fully understood, especially in cancer. We found that ammonia is not merely a toxic waste product but is recycled into central amino acid metabolism to maximize nitrogen utilization. In our experiments, human breast cancer cells primarily assimilated ammonia through reductive amination catalyzed by glutamate dehydrogenase (GDH); secondary reactions enabled other amino acids, such as proline and aspartate, to directly acquire this nitrogen. Metabolic recycling of ammonia accelerated proliferation of ...
Source: ScienceNOW - November 16, 2017 Category: Science Authors: Spinelli, J. B., Yoon, H., Ringel, A. E., Jeanfavre, S., Clish, C. B., Haigis, M. C. Tags: Biochemistry, Medicine, Diseases reports Source Type: news

NICE approves breakthrough breast cancer drugs
New class of cancer treatment drugs approved for NHS Related items fromOnMedica The genetics of breast cancer Ovarian cancer drug may help stall breast cancer Experts recommend anastrozole for postmenopausal women with family history of breast cancer (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 16, 2017 Category: UK Health Source Type: news

Diabetes May Be Driving High Rates of Breast Cancer in Black Women
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 15, 2017 Category: Cancer & Oncology Tags: Gynecology, Oncology, Diabetes, Preventive Medicine, News, Source Type: news

Diabetes Driving Breast Cancer Up in Black Women?
Type 2 diabetes may increase the risk for an aggressive type of breast cancer among black women in the United States, a new study finds. (Source: WebMD Health)
Source: WebMD Health - November 15, 2017 Category: Consumer Health News Source Type: news

Diabetes May Be Driving High Rates of Breast Cancer in Black Women
WEDNESDAY, Nov. 15, 2017 -- Type 2 diabetes may increase the risk for an aggressive type of breast cancer among black women in the United States, a new study finds. Researchers from Boston University analyzed data from more than 54,000 black women... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 15, 2017 Category: General Medicine Source Type: news

Diabetes May Be Driving High Rates of Breast Cancer in Black Women
Title: Diabetes May Be Driving High Rates of Breast Cancer in Black WomenCategory: Health NewsCreated: 11/15/2017 12:00:00 AMLast Editorial Review: 11/15/2017 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - November 15, 2017 Category: Endocrinology Source Type: news

Oncotarget: Researchers identify potential therapeutic target in aggressive breast cancer cells
(Rapamycin Press) An especially aggressive breast cancer cell can respond to hormone therapy if they express a specific protein known as estrogen receptor beta, according to research published in Oncotarget. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 15, 2017 Category: Cancer & Oncology Source Type: news

Type 2 diabetes associated with risk of aggressive breast cancer in black women
(Boston University School of Medicine) African American women with type 2 diabetes (often referred to as adult-onset diabetes) are at a greater risk for developing breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 15, 2017 Category: Cancer & Oncology Source Type: news

African-American women with type 2 diabetes may have higher risk for ER-neg breast cancer
(American Association for Cancer Research) Among African-American women, those with type 2 diabetes may have a higher risk of developing estrogen receptor (ER)-negative breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 15, 2017 Category: Cancer & Oncology Source Type: news

Diabetes May Be Driving High Rates of Breast Cancer in Black Women
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - November 15, 2017 Category: Cancer & Oncology Source Type: news

Low vitamin D linked to poorer fertility treatment outcomes
Time for clinical trial to see if supplements could boost live birth rate, say researchers Related items fromOnMedica Fertility treatments may impact on breast cancer risk Infertility Vitamin D deficiency increases risk of chronic headache Vitamin D supplements may cut risk of acute respiratory infections Vitamin D (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 15, 2017 Category: UK Health Source Type: news

Jax company starts trial on cancer-fighting therapy
Jacksonville-based TapImmune Inc. (Nasdaq: TPIV) has enrolled its final patient in a randomized, Phase 2 clinical study of an immunotherapy that targets breast cancer. TapImmune's therapies help the body's immune system find and fight cancer, which has evolved to hide from and suppress it, CEO Peter Hoang previously told the Business Journal. This approach is outside of the box of traditional treatment methods like surgery, chemotherapy and radiation therapy tha t shut-down pathways for cancer to… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - November 14, 2017 Category: American Health Authors: Will Robinson Source Type: news

SPM Conference
Discussions noted and collected will serve as the basis of a number of internal advocacy efforts. Let’s keep the conversation going on Connect! Our inaugural meeting was certified as Patients Included, a designation given to an event that meets all 5 of the Patients Included charter: Missed the event and couldn’t catch the live-stream? Loved the meeting so much you wish you could experience it all over again? We’ve got you covered! Here are speakers’ presentations from the inaugural Society for Participatory Medicine conference. Looking forward to our second annual meeting in 2018! Stay tuned for d...
Source: Society for Participatory Medicine - November 13, 2017 Category: General Medicine Authors: Nanette Mattox Tags: Newsletter Source Type: news

Nearly 1 in 3 Breast Cancer Pts Skip Adjuvant Therapy: Why? Nearly 1 in 3 Breast Cancer Pts Skip Adjuvant Therapy: Why?
A general distrust in the healthcare system, but not their personal physician, leads nearly 1 in 3 women with early breast cancer to opt out of or fail to complete adjuvant therapy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 13, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

FDA clears Cianna Medical ’ s Savi Scout breast cancer locator for long term implants
Cianna Medical said today that the Savi Scout reflector, part of its system for wire-free breast tumor localization, won FDA clearance as the first non-radioactive implant without a restriction on the length of time that the reflector can remain in a patient’s breast. The new clearance means that doctors can place Scout to mark a biopsy or lumpectomy site and not be constrained by a maximum implant time, the Aliso Viejo, Calif.-based company said. The Scout reflector also won’t interfere with MRI studies, so doctors aren’t restricted in the types of imaging modalities they can use with their patients. The...
Source: Mass Device - November 13, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Food & Drug Administration (FDA) Oncology Regulatory/Compliance Women's Health Cianna Medical Source Type: news

Researchers Build a Cancer Immunotherapy Without Immune Cells
A team has engineered two stem cell lines into 'synthetic T cells' that destroy breast cancer cells in vitro. (Source: The Scientist)
Source: The Scientist - November 13, 2017 Category: Science Tags: Daily News Source Type: news

Top Healthcare Trends Affecting Cancer Business in 2017 Impact Pathologists and Medical Laboratory Leaders Who Serve Oncologists and Patients
Many aspects of traditional clinical laboratory pathology testing remain rooted to cancer care even as the cancer care industry embraces precision medicine, and digital pathology testing and interpretation There’s good news for anatomic pathologists worried about the future of the pathology profession. A recent survey of oncology program participants in the United States determined that […] (Source: Dark Daily)
Source: Dark Daily - November 13, 2017 Category: Laboratory Medicine Authors: Jude Tags: Laboratory Management and Operations Laboratory Operations Laboratory Pathology Laboratory Testing Management & Operations ACCC Advisory Board Anthem Association of Community Cancer Care Centers Breast Cancer Ally Cancer Care Quality P Source Type: news

Emerging Therapeutic Strategies in Breast Cancer Emerging Therapeutic Strategies in Breast Cancer
Breast cancer treatment is undergoing a rapid evolution with recent advances in genomics, tumor biology, and immunology. Learn how this translates into new therapeutics in this review.Southern Medical Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 13, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Nonalcoholic fatty liver disease increases risk of liver, colorectal, and breast cancers
(Elsevier) Nonalcoholic fatty liver disease (NAFLD) is one of the more common chronic liver diseases worldwide. It is associated with metabolic syndrome (i.e. insulin resistance and diabetes) and predisposes to cardiovascular disease. In a new study published in the Journal of Hepatology, researchers identified links not only between NAFLD and hepatocellular carcinoma (HCC), which have been well established, but also to cancers outside the liver, including colorectal and breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 13, 2017 Category: Cancer & Oncology Source Type: news

Epigenetic editing reveals surprising insights into early breast cancer development
(Queen Mary University of London) Changing the epigenetic code of a single gene is enough to cause a healthy breast cell to begin a chain reaction and become abnormal, according to research by Queen Mary University of London (QMUL). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 13, 2017 Category: International Medicine & Public Health Source Type: news

Cancer Carepoint brings no-cost care to Silicon Valley
Editor's note: Each year, the Silicon Valley Business Journal honors area groups and individuals who have made a significant difference in our community. Cancer Carepoint is one of our three Community Impact honorees this year. For Ann Marie Bongiorno, asking for help is not easy. But in the past few years, she’s learned it is lifesaving. In 2012, Bongiorno was diagnosed with Stage 3 breast cancer, and she quickly realized she was not alone, and could ask for help. That’s when she discovered… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 11, 2017 Category: Biotechnology Authors: Kevin Burbach Source Type: news

Cancer Carepoint brings no-cost care to Silicon Valley
Editor's note: Each year, the Silicon Valley Business Journal honors area groups and individuals who have made a significant difference in our community. Cancer Carepoint is one of our three Community Impact honorees this year. For Ann Marie Bongiorno, asking for help is not easy. But in the past few years, she’s learned it is lifesaving. In 2012, Bongiorno was diagnosed with Stage 3 breast cancer, and she quickly realized she was not alone, and could ask for help. That’s when she discovered… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 11, 2017 Category: Pharmaceuticals Authors: Kevin Burbach Source Type: news